KOHJIN BIO CO LTD (177A.T)

JPY 1670.0

(3.73%)

Net Debt Summary of KOHJIN BIO CO LTD

  • KOHJIN BIO CO LTD's latest annual net debt in 2023 was 742.75 Million JPY , up 16.51% from previous year.
  • KOHJIN BIO CO LTD's latest quarterly net debt in 2023 FY was 742.75 Million JPY , up 16.51% from previous quarter.
  • KOHJIN BIO CO LTD reported annual net debt of 637.53 Million JPY in 2022, up 28.97% from previous year.
  • KOHJIN BIO CO LTD reported annual net debt of 494.31 Million JPY in 2021, down 0.0% from previous year.
  • KOHJIN BIO CO LTD reported quarterly net debt of 742.75 Million JPY for 2023 Q4, up 17.46% from previous quarter.
  • KOHJIN BIO CO LTD reported quarterly net debt of 632.35 Million JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Net Debt Chart of KOHJIN BIO CO LTD (2023 - 2021)

Historical Annual Net Debt of KOHJIN BIO CO LTD (2023 - 2021)

Year Net Debt Net Debt Growth
2023 742.75 Million JPY 16.51%
2022 637.53 Million JPY 28.97%
2021 494.31 Million JPY 0.0%

Peer Net Debt Comparison of KOHJIN BIO CO LTD

Name Net Debt Net Debt Difference
PRISM BioLab Co.,LTD -1.13 Billion JPY 165.502%
GNI Group Ltd. -17.93 Billion JPY 104.142%
Linical Co., Ltd. -4.46 Billion JPY 116.642%
Trans Genic Inc. -221.16 Million JPY 435.833%
MEDINET Co., Ltd. -4.39 Billion JPY 116.904%
Soiken Holdings Inc. -4.79 Billion JPY 115.506%
Cytori Cell Research Institute, Inc. 1.43 Billion JPY 48.187%
AnGes, Inc. -3.79 Billion JPY 119.558%
OncoTherapy Science, Inc. -420.8 Million JPY 276.508%
Nxera Pharma Co., Ltd. 24.9 Billion JPY 97.018%
Immuno-Biological Laboratories Co., Ltd. -498.15 Million JPY 249.102%
NanoCarrier Co., Ltd. -466.34 Million JPY 259.272%
Carna Biosciences, Inc. -2.7 Billion JPY 127.447%
CanBas Co., Ltd. -1.88 Billion JPY 139.337%
D. Western Therapeutics Institute, Inc. -982.14 Million JPY 175.626%
RaQualia Pharma Inc. -3.39 Billion JPY 121.865%
Chiome Bioscience Inc. -1.03 Billion JPY 171.795%
Kidswell Bio Corporation 343.58 Million JPY -116.177%
PeptiDream Inc. 3.29 Billion JPY 77.437%
Oncolys BioPharma Inc. -972.59 Million JPY 176.369%
Ribomic Inc. -2.09 Billion JPY 135.374%
SanBio Company Limited -3.78 Billion JPY 119.599%
Healios K.K. -2.19 Billion JPY 133.916%
BrightPath Biotherapeutics Co., Ltd. -944.85 Million JPY 178.61%
Kubota Pharmaceutical Holdings Co., Ltd. -2.62 Billion JPY 128.305%
Delta-Fly Pharma, Inc. -1.41 Billion JPY 152.415%
StemRIM -8.41 Billion JPY 108.832%
CellSource Co., Ltd. -4.68 Billion JPY 115.859%
FunPep Company Limited -1.79 Billion JPY 141.417%
Kringle Pharma, Inc. -2.13 Billion JPY 134.765%
Stella Pharma Corporation -1.11 Billion JPY 166.353%
TMS Co., Ltd. -3.44 Billion JPY 121.55%
Noile-Immune Biotech Inc. -5.55 Billion JPY 113.369%
Cuorips Inc. -5.56 Billion JPY 113.357%
K Pharma,Inc. -3.26 Billion JPY 122.739%
Takara Bio Inc. -32.2 Billion JPY 102.306%
ReproCELL Incorporated -2.93 Billion JPY 125.272%
PhoenixBio Co., Ltd. -660.96 Million JPY 212.376%
StemCell Institute Inc. -2.83 Billion JPY 126.183%
Japan Tissue Engineering Co., Ltd. -2.06 Billion JPY 135.946%
CellSeed Inc. -2.01 Billion JPY 136.916%